Literature DB >> 7491550

The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking.

C Frost1, F M Fullerton, A M Stephen, R Stone, A Nicolaides-Bouman, J Densem, N J Wald, A Semmence.   

Abstract

BACKGROUND: Observational and short term intervention studies have reported that smokers of low tar cigarettes inhale more deeply (that is, compensate) than those who smoke high tar cigarettes. To quantify this effect a long term randomised trial was conducted on the effects of switching to low tar cigarettes.
METHODS: The trial was carried out between April 1985 and March 1988 among cigarette smokers in the British Civil Service, measuring blood carboxyhaemoglobin (COHb) levels and serum cotinine levels as markers of tobacco smoke intake. Volunteers first switched to a cigarette brand yielding around 10% less tar than their usual brand to identify smokers able to change brand. The 434 subjects who successfully switched were then randomly allocated to one of three groups: (a) "fast reduction" group which changed to a brand of cigarettes with a tar yield of about half that of their usual brand; (b) "slow reduction" group which reduced to the same level in steps over several months; and (c) a control group which continued smoking cigarettes with a tar yield 10% lower than their usual brand.
RESULTS: Over the course of the trial cigarette consumption declined slightly in all three groups. In both the "fast reduction" and the "slow reduction" groups, intake of COHb and cotinine was reduced, though not to the same extent as the yield reduction. Comparison of the results before randomisation with those at the end of the trial showed that a reduction in carbon monoxide yield of 45% was associated with a decrease in carbon monoxide intake of 19% (95% confidence interval 14% to 24%) and that a reduction in nicotine yield of 40% was associated with an 11% (6% to 16%) reduction in nicotine intake, reflecting relative intakes of about 1.5 for both carbon monoxide and nicotine in the "fast reduction" group. Results were similar in the "slow reduction" group with a 42% reduction in carbon monoxide yield, a 16% (11% to 22%) reduction in carbon monoxide intake, a 37% reduction in nicotine yield, and a 6% (0% to 13%) reduction in nicotine intake. Estimates of compensation derived from these results were 65% for carbon monoxide, 79% for nicotine, and 62% for tar.
CONCLUSIONS: Compensation, demonstrated when switching from a high tar cigarette to a low tar one, was incomplete. Advising people who have failed to give up smoking to switch to low tar cigarettes will reduce the intake of smoke constituents to a small extent. This would be expected to decrease their risk of smoking-related diseases, although by a smaller amount than would be achieved by giving up smoking altogether.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491550      PMCID: PMC475015          DOI: 10.1136/thx.50.10.1038

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  3 in total

1.  Smoking, carbon monoxide and arterial disease.

Authors:  N Wald; S Howard
Journal:  Ann Occup Hyg       Date:  1975-08

2.  Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies.

Authors:  G J Knight; P Wylie; M S Holman; J E Haddow
Journal:  Clin Chem       Date:  1985-01       Impact factor: 8.327

3.  Cotinine disposition and effects.

Authors:  N L Benowitz; F Kuyt; P Jacob; R T Jones; A L Osman
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

  3 in total
  7 in total

1.  The future of tobacco product regulation and labelling in Europe: implications for the forthcoming European Union directive.

Authors:  C Bates; A McNeill; M Jarvis; N Gray
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

Review 3.  Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Authors:  Min-Ae Song; Neal L Benowitz; Micah Berman; Theodore M Brasky; K Michael Cummings; Dorothy K Hatsukami; Catalin Marian; Richard O'Connor; Vaughan W Rees; Casper Woroszylo; Peter G Shields
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

Review 4.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 5.  Interventions to reduce harm from continued tobacco use.

Authors:  Nicola Lindson-Hawley; Jamie Hartmann-Boyce; Thomas R Fanshawe; Rachna Begh; Amanda Farley; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

6.  Longitudinal study of long-term smoking behaviour by biomarker-supported determination of exposure to smoke.

Authors:  Anthony Cunningham; Johan Sommarström; Ajit S Sisodiya; Graham Errington; Krishna Prasad
Journal:  BMC Public Health       Date:  2014-04-12       Impact factor: 3.295

7.  Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims.

Authors:  Lucy Popova; Lauren Kass Lempert; Stanton A Glantz
Journal:  Tob Control       Date:  2018-09-12       Impact factor: 7.552

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.